These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3957740)

  • 1. The accuracy of the line and point source approximations in Ir-192 dosimetry.
    Williamson JF
    Int J Radiat Oncol Biol Phys; 1986 Mar; 12(3):409-14. PubMed ID: 3957740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brachytherapy implants with differently spaced Ir-192 seeds: a dosimetric study.
    Muller-Runkel R; Vijayakumar S
    Radiology; 1987 Oct; 165(1):271-4. PubMed ID: 3628781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monte Carlo dosimetric study of best industries and Alpha Omega Ir-192 brachytherapy seeds.
    Ballester F; Granero D; Pérez-Calatayud J; Casal E; Puchades V
    Med Phys; 2004 Dec; 31(12):3298-305. PubMed ID: 15651612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of geometric errors in the reconstruction of iridium-192 seed implants.
    Rosen II; Khan KM; Lane RG; Kelsey CA
    Med Phys; 1982; 9(2):220-3. PubMed ID: 7087907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative dosimetry between iridium wires and seed ribbons.
    Marinello G; Valero M; Leung S; Pierquin B
    Int J Radiat Oncol Biol Phys; 1985 Sep; 11(9):1733-9. PubMed ID: 4030441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric characterization of the M-15 high-dose-rate Iridium-192 brachytherapy source using the AAPM and ESTRO formalism.
    Ho Than MT; Munro Iii JJ; Medich DC
    J Appl Clin Med Phys; 2015 May; 16(3):5270. PubMed ID: 26103489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of seed anisotrophy on brachytherapy dose distributions using 125I and 103Pd.
    Lindsay P; Battista J; Van Dyk J
    Med Phys; 2001 Mar; 28(3):336-45. PubMed ID: 11318315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
    Chibani O; Williamson JF; Todor D
    Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of new GAFCHROMIC EBT film for 125I seed dosimetry in Solid Water phantom.
    Chiu-Tsao ST; Medich D; Munro J
    Med Phys; 2008 Aug; 35(8):3787-99. PubMed ID: 18777938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of encapsulated 170Tm sources for their potential use in brachytherapy.
    Ballester F; Granero D; Perez-Calatayud J; Venselaar JL; Rivard MJ
    Med Phys; 2010 Apr; 37(4):1629-37. PubMed ID: 20443484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monte Carlo calculated TG-43 dosimetry parameters for the SeedLink 125Iodine brachytherapy system.
    Medich DC; Munro JJ
    Med Phys; 2003 Sep; 30(9):2503-8. PubMed ID: 14528972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 192Ir nomogram system for single plane implants.
    Murphy DJ; Memula N; Doss LL
    Int J Radiat Oncol Biol Phys; 1986 Feb; 12(2):267-70. PubMed ID: 3949578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric accuracy of a deterministic radiation transport based 192Ir brachytherapy treatment planning system. Part I: single sources and bounded homogeneous geometries.
    Zourari K; Pantelis E; Moutsatsos A; Petrokokkinos L; Karaiskos P; Sakelliou L; Georgiou E; Papagiannis P
    Med Phys; 2010 Feb; 37(2):649-61. PubMed ID: 20229874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate brachytherapy postimplant dosimetry: seed orientation and the impact of dosimetric anisotropy in stranded implants.
    Chng N; Spadinger I; Rasoda R; Morris WJ; Salcudean S
    Med Phys; 2012 Feb; 39(2):721-31. PubMed ID: 22320782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy assessment of the superposition principle for evaluating dose distributions of elongated and curved 103Pd and 192Ir brachytherapy sources.
    Bannon EA; Yang Y; Rivard MJ
    Med Phys; 2011 Jun; 38(6):2957-63. PubMed ID: 21815369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric characterization of 142Pr glass seeds for brachytherapy.
    Jung JW; Reece WD
    Appl Radiat Isot; 2008 Apr; 66(4):441-9. PubMed ID: 18171619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGSnrc-based Monte Carlo dosimetry of CSA1 and CSA2 137Cs brachytherapy source models.
    Selvam TP; Sahoo S; Vishwakarma RS
    Med Phys; 2009 Sep; 36(9):3870-9. PubMed ID: 19810459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An approach to using conventional brachytherapy software for clinical treatment planning of complex, Monte Carlo-based brachytherapy dose distributions.
    Rivard MJ; Melhus CS; Granero D; Perez-Calatayud J; Ballester F
    Med Phys; 2009 Jun; 36(6):1968-75. PubMed ID: 19610285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric characteristics, air-kerma strength calibration and verification of Monte Carlo simulation for a new Ytterbium-169 brachytherapy source.
    Perera H; Williamson JF; Li Z; Mishra V; Meigooni AS
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):953-70. PubMed ID: 8138449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetry of CT-guided volumetric IR-192 brain implant.
    Abrath FG; Henderson SD; Simpson JR; Moran CJ; Marchosky JA
    Int J Radiat Oncol Biol Phys; 1986 Mar; 12(3):359-63. PubMed ID: 3957734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.